8 months ago
CAPR
AnalystsBoobalan PachaiyappanBoobalan Pachaiyappan's Stock Forecasts
AnalystsBoobalan Pachaiyappan
Sectors:
Industries:
Analyst Ranking
Top 18%
#943 out of 5327 analysts
Average Return
+17.19%
Win Rate
55%18 out of 33
Risk vs Reward
Poor
Good
Boobalan Pachaiyappan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Capricor Therapeutics IncCAPR | +232.20% | $5.87 | $19.50 | 2025-11-12 - 2026-07-20 | Strong Buy |
Capricor Therapeutics IncCAPR | +179.08% | $7.39 | $20.61 | 2025-07-14 - 2026-07-13 | Strong Buy |
Verona Pharma PLCVRNA | +136.53% | $45.20 | $106.91 | 2025-01-10 - 2025-10-07 | Strong Buy |
Capricor Therapeutics IncCAPR | +113.70% | $12.19 | $26.05 | 2025-06-17 - 2026-06-16 | Strong Buy |
Cervomed IncCRVO | +105.93% | $2.36 | $4.86 | 2025-03-11 - 2026-03-10 | Strong Buy |
Boobalan Pachaiyappan Analyst Color
Get additional color on Boobalan Pachaiyappan's coverage of popular stocks
a year ago
CRVO
a year ago
CRVO
Boobalan Pachaiyappan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Promis Neurosciences IncPMN | 1 | Strong Buy | $19.00 | +26.04% | Initiates Coverage On | 14 days ago |
Annovis Bio IncANVS | 1 | Strong Buy | $8.00 | +373.37% | Initiates Coverage On | 14 days ago |
Coya Therapeutics IncCOYA | 1 | Strong Buy | $12.00 | +170.27% | Initiates Coverage On | 2 months ago |
Reviva Pharmaceuticals Holdings IncRVPH | 3 | Strong Buy | $1.00 | +203.03% | Maintains | 4 months ago |
Cingulate IncCING | 5 | Strong Buy | $14.00 | +207.02% | Maintains | 4 months ago |
Cervomed IncCRVO | 5 | Strong Buy | $11.00 | +294.27% | Maintains | 4 months ago |
Neurosense Therapeutics LtdNRSN | 1 | Strong Buy | $3.00 | +334.78% | Initiates Coverage On | 4 months ago |
Ovid Therapeutics IncOVID | 1 | Strong Buy | $3.00 | +30.15% | Initiates Coverage On | 7 months ago |
Polypid LtdPYPD | 3 | Strong Buy | $9.00 | +74.76% | Maintains | 8 months ago |
Capricor Therapeutics IncCAPR | 3 | Strong Buy | $13.00 | -33.33% | Maintains | 8 months ago |
Avidity Biosciences IncRNAM | 1 | Strong Buy | $62.00 | +320.34% | Initiates Coverage On | 10 months ago |
Longeveron IncLGVN | 2 | Strong Buy | $3.00 | +398.34% | Maintains | a year ago |
Gain Therapeutics IncGANX | 3 | Strong Buy | $6.00 | +268.10% | Maintains | a year ago |
Verona Pharma PLCVRNA | 2 | Strong Buy | $116.00 | N/A | Reiterates | a year ago |
Entrada Therapeutics IncTRDA | 1 | Strong Buy | $29.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.